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j ourna l homepage: www.e lsev ie r .com/ locate /bonrEditorialThe birth of Bone ReportsA great legacy of a deeper understanding of the molecular signaling
systems within and between bone cells has been the development of
therapeutic agents to treat osteoporosis and thus prevent fragility
fractures. This research discipline has grown very rapidly since the
late 1980s and has been underpinned by excellence in the ﬁelds of
mouse genetics, basic bone cell biology, preclinical research in animal
models, and clinical research involving large multicentre randomized
controlled trials in humans. In parallel, bone imaging techniques for
measuring skeletal fragility in animal models and humans have also
rapidly evolved, so that trabecular and cortical microstructure may
now be visualized with high resolution. The journal Bone has provided
a stimulating interdisciplinary forum for the critical review of these
new methods and has been a home for many discoveries into bone
and mineral metabolism, bone structure and imaging techniques. It
has pioneered rapid on-line publication of both original articles and re-
views on basic, translational, and clinical aspects of bone and mineral
metabolism. Bone also encourages submissions related to interactions
of bone with other organ systems, including cartilage, endocrine,
muscle, fat, neural, vascular, gastrointestinal, hematopoietic, and
immune systems. Particular attention is placed on translational research
and the application of experimental studies to clinical practice.
Because of the rapid growth in the discipline of bone and mineral
metabolism, the need for a sister journal became apparent a few years
ago, as many high quality papers were rejected by Bone. At the same
time, there has been widespread concern about a surprising lack of re-
producibility in preclinical research studies. The leaders of the National
Institutes of Health in USA, Francis S. Collins and Lawrence A. Tabak,
have addressed this concern by announcing a number of actions, includ-
ing supporting researcher training on enhanced reproducibility and
transparency of research ﬁndings underpinned by good experimental
design. As a response to this concern, the ARRIVE guidelines for
reporting animal research were also proposed to improve bioscience
reporting, but have not as yet been widely enforced by all Journals. By
contrast, in clinical studies involving humans, the use of the analogous
CONSORT guidelines has been widely enforced by Journals. This is
where Bone Reports comes in. While it is exciting and excellent to pub-
lish ﬁrst, it is even better when those initial experimental observations
are then conﬁrmed and extended by other scientists in the discipline.
Bone Reports aims tomake this important role of study conﬁrmation
and extension of ﬁndings less difﬁcult to achieve. Bone Reports is a newhttp://dx.doi.org/10.1016/j.bonr.2015.02.001
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Bone, Bone Reports is an interdisciplinary forum for the rapid publication
of original research articles, and also case reports, across basic, transla-
tional and clinical aspects of bone and mineral metabolism. The Journal
aims to publish papers that are scientiﬁcally sound, with the peer
review process focused principally on verifying sound methodologies,
and correct data analysis and interpretation. The Journal therefore
welcomes studies either replicating or failing to replicate a previous
study, and those with null ﬁndings. We believe Bone Reports fulﬁlls
the recently highlighted critical and current need to enhance research
by publishing reproducibility studies and null ﬁndings.
As Editor-in-Chief, one of my aspirations for Bone Reports is that it
further drives forward the research into bone biology that has
underpinned the exciting therapeutic advances in the discipline of
bone and mineral metabolism. It is only with methodologically sound
and reproducible preclinical research studies, acknowledging the
possible limitations of new technologies, that expensive clinical studies
involving humans can be carefully planned and successfully completed.
We see the role of the Journal as a cornerstone to support and nurture
this scientiﬁc area, offering a platform to optimize and solidify the
impact of emergent ﬁndings and to offer, too, the opportunity for
doctors to gain insight into pathophysiological mechanisms in bone
andmineral diseases through the publication of illustrative high quality
case reports.
As a sister journal to Bone, we are in a unique position of being able
to draw on the talents of a remarkable pool of experienced, expert
reviewers and talented editors who have made Bone the home to
some of the most exciting discoveries into bone and mineral metabo-
lism, bone structure and imaging techniques. This support allows us to
make Bone Reports an innovative home for improving scientiﬁc repro-
ducibility in preclinical and translational research to further inform
therapeutic interventions to improve the musculoskeletal health of
our communities.
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